Gene: ARL3
Official Full Name: ARF like GTPase 3provided by HGNC
Gene Summary: Enables GDP binding activity; GTP binding activity; and microtubule binding activity. Involved in several processes, including cilium assembly; protein localization to cilium; and small GTPase-mediated signal transduction. Acts upstream of or within post-Golgi vesicle-mediated transport. Located in several cellular components, including microtubule cytoskeleton; midbody; and photoreceptor connecting cilium. Implicated in Joubert syndrome and retinitis pigmentosa 83. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38920 | ARL3 Knockout cell line (HeLa) | Human | ARL3 | 1:3~1:6 | Negative | Online Inquiry |
KO38921 | ARL3 Knockout cell line (HCT 116) | Human | ARL3 | 1:2~1:4 | Negative | Online Inquiry |
KO38922 | ARL3 Knockout cell line (HEK293) | Human | ARL3 | 1:3~1:6 | Negative | Online Inquiry |
KO38923 | ARL3 Knockout cell line (A549) | Human | ARL3 | 1:3~1:4 | Negative | Online Inquiry |
ARL3 Gene Knockout Cell Lines are specialized cellular models that have had the ARL3 gene, known for its role in regulating protein trafficking and microtubule dynamics, specifically disrupted through targeted genetic modification. These cell lines serve as invaluable tools for understanding the functional consequences of ARL3 deficiency, particularly in areas such as cellular signaling, ciliary function, and neuronal activities.
The primary mechanism by which ARL3 knockout operates involves impairing the normal GTPase signaling pathway, which is crucial for various biological processes, including intracellular transport and development of cilia. By studying these knockout cell lines, researchers can uncover the cellular and molecular repercussions of altered ARL3 activity, enabling insights into related pathologies such as ciliopathies and neurodegenerative diseases.
In scientific research and clinical applications, ARL3 Gene Knockout Cell Lines are pivotal in elucidating the gene’s role in both normal physiology and disease states. They allow for the investigation of potential therapeutic targets and drug responses in genetically relevant contexts, leading to advancements in personalized medicine approaches.
Compared to alternative models, such as traditional wild-type cell lines or less targeted knockdown approaches, ARL3 knockout cell lines provide a more precise and reliable platform for studying the specific impact of ARL3 alterations. This specificity enhances the reproducibility of results, allowing scientists to draw more accurate conclusions in their experiments.
For researchers and clinicians seeking to explore the intricacies of ARL3's role in cellular functions, these knockout cells offer a unique value proposition. They not only facilitate the identification of new pathways for therapeutic intervention but also contribute to the broader understanding of gene function in health and disease.
At our company, we pride ourselves on delivering high-quality, genetically modified cell lines backed by extensive expertise in genetic engineering, ensuring that our products meet the rigorous standards required for cutting-edge scientific research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.